Bioscience Development Inc.

New York, NY

UEI
TRCELQ72NMC3
CAGE
42UP1
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Sole Proprietorship
SAM.gov registration date
Physical address
T.H.I.S Town House international School, 1199 Park Ave #3G, New York, NY 10128, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
CSF proteome of post treatment lyme disease R21AI196340 National Institute of Allergy and Infectious Diseases (NIH) $210,000
Development of diagnostic test for early multiple sclerosis R43NS090908 National Institutes of Health $250,368
Development of molecular diagnostic test for early onset of lyme disease R44AI114009 National Institute of Allergy and Infectious Diseases (NIH) $2,346,762
Development of molecular diagnostic test for early onset of lyme disease R43AI114009 National Institutes of Health $294,467
Broad detection system for tick-borne pathogens R44AI077156 National Institutes of Health $3,010,977

Quick answers

Is Bioscience Development Inc. registered in SAM.gov?

Yes. Bioscience Development Inc.'s SAM.gov registration is active through November 10, 2026.

What is Bioscience Development Inc.'s most recent federal award?

Bioscience Development Inc.'s most recent federal grant award is CSF proteome of post treatment lyme disease (R21AI196340), from National Institute of Allergy and Infectious Diseases (NIH), on September 1, 2026.

On GovTribe

See Bioscience Development Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login